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ABSTRACT 1 
Background: In our ageing population, maintenance of bone health is critical to reduce the 2 
risk of osteoporosis and potentially debilitating consequences of fractures in older individuals. 3 
Amongst modifiable lifestyle and dietary factors, dietary magnesium and potassium intake are 4 
postulated to influence bone quality and osteoporosis, principally via calcium-dependent 5 
alteration of bone structure and turnover. 6 
Objective: To investigate the influence of dietary magnesium and potassium intakes, and 7 
circulating magnesium, on bone density status and fracture risk in a UK adult population. 8 
Design: A random subset of 4000 individuals from the EPIC-Norfolk cohort of 25,639 men 9 
and women with baseline data was used for bone density cross-sectional analyses, and 10 
combined with fracture cases (n=1502) for fracture case-cohort longitudinal analyses (mean 11 
follow-up 13.4 years). Relevant biological, lifestyle, and dietary covariates were used in 12 
multivariate regression analyses to determine associations between dietary magnesium and 13 
potassium intakes and calcaneal broadband ultrasound attenuation (BUA), and in Prentice-14 
weighted Cox regression to determine associated risk of fracture. Separate analyses, 15 
excluding dietary covariates, investigated associations of BUA and fractures with serum 16 
magnesium concentration. 17 
Results: Significant positive trends in calcaneal BUA for women (n=1360), but not men 18 
(n=968), were apparent across increasing quintiles of Mg+K z-score intake (p=0.03), or 19 
potassium intake alone (p=0.04). Reduced hip fracture risk in both men (n=1958) and women 20 
(n=2755) was evident for individuals in specific Mg+K z-score intake quintiles versus the 21 
lowest. Significant trends in fracture risk in men across serum magnesium concentration 22 
groups were apparent for spine fractures (p=0.02), and total hip, spine, and wrist fractures 23 
(p=0.02). None of these individual significant associations remained after adjusting for 24 
multiple-testing. 25 
3 
Conclusions: These findings enhance the limited literature studying the association of 26 
magnesium and potassium with bone density and demonstrate that further investigation is 27 
warranted into the mechanisms involved and the potential protective role against osteoporosis. 28 
4 
INTRODUCTION 29 
A multitude of factors are known to influence bone health, including modifiable factors such 30 
as diet, physical activity, and smoking, but also age, sex, and genetics (1). Osteoporosis, 31 
characterised by bone loss due to deterioration of bone microarchitecture and consequent 32 
increased risk of fracture, is significantly associated with age and thus represents a major 33 
public health concern for our ageing population (2). Calcium and vitamin D have traditionally 34 
been the primary nutritional candidates for osteoporosis prevention and maintenance of bone 35 
health (3), but more recently magnesium intake has also been linked with bone mass, and 36 
magnesium deficiency with osteoporosis (4-8). Magnesium is a major component of bone, 37 
with 67% of total body magnesium found there (9). Animal studies have suggested a number 38 
of mechanisms for involvement of magnesium in bone metabolism including: nitric oxide 39 
dependent effects on osteoblast activity and osteoclast number (10); influence of magnesium 40 
on hydroxyapatite crystal formation and consequent bone stiffness (11); regulation of calcium 41 
homeostasis through parathyroid hormone, 1,25-dihydroxyvitamin D, and magnesium-42 
dependent calcium channels (9); and altered inflammatory cytokine release (12). Similarly, 43 
recent epidemiological studies have associated lower dietary potassium intake with poorer 44 
bone density (5, 6, 8, 13). Increasing potassium intake increases urinary retention, reducing 45 
loss of calcium and thus creating a more positive calcium balance and inhibiting bone 46 
resorption; urinary loss of phosphorus also decreases, which inhibits renal synthesis of 1,25-47 
dihydroxyvitamin D and cuts intestinal absorption of calcium, stopping the positive calcium 48 
balance persisting (14). Occurrence of this stabilisation has recently been disputed, although 49 
potassium source differences may be the cause of the discrepancy between studies (15). 50 
 51 
When considering the dietary association of magnesium and potassium with bone health it is 52 
most appropriate to study these minerals concurrently as they are frequently consumed 53 
5 
together from intact or moderately altered plant or animal tissues (16). Metabolism of 54 
magnesium and potassium are linked as magnesium is required for effective Na+/K+-ATPase 55 
pump function (17), magnesium and potassium have additive effects in preventing increase in 56 
the endogenous sodium potassium pump inhibitor (16), and both have direct and indirect 57 
effects on calcium homeostasis (9, 18). Previous studies of the association of dietary 58 
magnesium and potassium with bone health have had limited generalisability due to their 59 
focus on discrete population groups, such as narrow age-range groups of relatively old (5, 19) 60 
or young individuals (20), restrictions to pre- (8, 20) or post-menopausal women only (13), 61 
and non-UK residents (5, 7, 20). Indeed, the most recent and comprehensive study, with a 62 
large cohort size and longitudinal analysis of fracture risk, was also limited to women only (7). 63 
The current study therefore aimed to explore potential associations of dietary magnesium and 64 
potassium intakes and circulating magnesium with bone density status and risk of incident 65 
osteoporotic fractures in a general population of men and women in the UK, using a measure 66 
of broadband ultrasound attenuation of the calcaneus and records of incident fractures of the 67 
hip, spine, and wrist. 68 
6 
SUBJECTS AND METHODS 69 
The EPIC-Norfolk cohort analysed in this study is part of the European Prospective 70 
Investigation into Cancer (EPIC), a global collaboration involving ten countries developed 71 
primarily to examine association between diet and cancer, with additional health outcomes 72 
also examined in EPIC-Norfolk. This cohort has been described in detail previously (21), but 73 
in brief the Norfolk cohort consisted of 25,639 men and women aged 40-79 years old living in 74 
the general community who participated in a baseline health-check between 1993 and 1997. A 75 
second health-check was attended by 15,786 participants, aged 42-82 years between 1997 and 76 
2000, when quantitative ultrasound measurements of the calcaneus (heel bone) were 77 
performed according to standardised protocols using a CUBA (contact ultrasound bone 78 
analyser) device (McCue Ultrasonics, Winchester, United Kingdom). Quantitative ultrasound 79 
represents a cheaper, more rapid, and easier method of assessing bone density status in 80 
general practice compared to the gold-standard of Dual X-ray absorptiometry (DXA), and has 81 
been shown capable of predicting fracture risk (22). Measurements of broadband ultrasound 82 
attenuation (BUA; dB/MHz) from each foot were taken at least in duplicate and the mean of 83 
both feet was recorded, as described previously (22). 84 
 85 
The dataset analysed here includes 4000 randomly selected participants with baseline health-86 
check data, plus a group of 1502 participants with fractures, representing all hip, spine, and 87 
wrist fracture cases in the cohort up to 31st March 2009. Some overlap exists between the 88 
random subcohort and the fracture cases and thus the fracture case-cohort contains 5319 89 
unique individuals (4713 participants had complete data for diet and fracture analyses; 3469 90 
for serum and fracture analyses). Ultrasound data was available for 2341 individuals (2328 91 
participants had complete data for diet and ultrasound analyses; 1726 for serum and 92 
ultrasound analyses). 93 
7 
 94 
The Norfolk District Health Authority Ethics Committee approved all procedures involving 95 
human subjects and written informed consent was provided by all participants according to 96 
the Declaration of Helsinki. 97 
 98 
Height and weight were measured according to standard protocols (21) at both health checks, 99 
conducted either at a clinic or the participant’s GP surgery. Height was determined to the 100 
nearest millimetre using a free-standing stadiometer. Weight was recorded to the nearest 0.2 101 
kilograms with the participant wearing light clothing and no shoes. BMI was calculated from 102 
these measurements (kg/m2). 103 
 104 
Participants also completed a self-administered health and lifestyle questionnaire (HLQ) at 105 
both health checks. This included smoking status categorised as current, former or never; 106 
family history of osteoporosis categorised as yes or no; menopausal status (women only) 107 
categorised as pre-menopausal, peri-menopausal (<1 year), peri-menopausal (1-5 years), or 108 
post-menopausal; and HRT status (women only) categorised as current, former, or never 109 
users. A short physical activity questionnaire was used to assess typical physical activity over 110 
the previous 12 months. Physical activity levels were then categorised into inactive, 111 
moderately inactive, moderately active, and active categories by a method validated against 112 
heart-rate monitoring data (21, 23). 113 
 114 
Dietary intake of each participant was assessed by using a 7 day food diary (24), with each 115 
participant recording all food and drink consumed within a 7 day period, as well as the 116 
portion sizes. This method has previously been validated, proving more accurate in estimating 117 
dietary nutrient intake than food-frequency questionnaires (FFQ) (21, 25). Detail of the 118 
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DINER (Data Into Nutrients for Epidemiological Research) software used to record and 119 
translate the dietary information provided by the 7-day food diaries into nutrient quantities is 120 
reported elsewhere (26). All data entries were checked by nutritionists trained in use of the 121 
system (27). 122 
 123 
Serum magnesium concentration was determined using blood sampled by peripheral 124 
venepuncture during the baseline health check. Samples were stored in liquid nitrogen at -125 
196ºC until analysed by Quotient Bioresearch, Fordham, UK, using an Olympus AU640 126 
Chemistry Immuno Analyser to perform a xylidyl blue based colorimetric assay. 127 
 128 
Fracture incidence data were collected by questionnaire at baseline and follow-up health 129 
checks. In addition the East Norfolk Health Authority database (ENCORE), which records all 130 
hospital contact Norfolk residents have in England and Wales, was available to EPIC 131 
researchers for data linkage (28). This enabled the incidence of osteoporotic fractures 132 
occurring in the cohort, up to the end of March 2009, to be determined by retrieving data 133 
using the NHS numbers of EPIC participants and the International Classification of Diseases 134 
(ICD) 9 and 10 diagnostic codes for osteoporotic fractures by site (hip, spine, and wrist). 135 
 136 
Statistical analyses 137 
Statistical analyses were performed using STATA statistical software (version 12; Stata Corp., 138 
College Station, Tx). All analyses were stratified by sex since significant differences in age-139 
related changes in bone between men and women have previously been reported for this 140 
population, with a much greater magnitude of deterioration evident in women (22). 141 
Hypotheses and covariates included in regression models were well defined a priori using 142 
evidence from previous research and thus p-values ≤0.05 were considered to be statistically 143 
9 
significant in individual analyses. The individual hypotheses tested in this study have been 144 
grouped into families of tests (Supplemental Table 1), allowing the significance of 145 
individual p values to be determined in comparison to a Bonferroni-generated family-wise 146 
critical p value. 147 
 148 
Due to the high degree of collinearity between magnesium and potassium dietary intakes 149 
(Pearson r=0.84 and r=0.82 in men and women, both p<0.001) and thus the potential for 150 
statistical issues, and any independent effects to be diminished, a summation of magnesium 151 
and potassium intake was used as the main exposure; however, since the amounts of each 152 
mineral consumed varies widely, both minerals were standardised before summation, 153 
resulting in a Mg+K z-score intake variable (5).  154 
 155 
Univariate linear regression was used to estimate the association of selected biological, 156 
lifestyle and dietary factors with sex-specific quintiles of dietary magnesium, potassium, or 157 
Mg+K z-score intake. Multivariable regression with ANCOVA was used to investigate 158 
differences in calcaneal BUA across sex-specific quintiles of dietary magnesium, potassium, 159 
or Mg+K z-score intake. An adjusted model was tested, correcting for the potential effects of 160 
biological (age, BMI, family history of osteoporosis, menopausal status, HRT status, 161 
corticosteroid use), lifestyle (smoking status, and physical activity) and dietary factors 162 
(calcium intake (29, 30), total energy intake (31), and calcium and vitamin D supplement use, 163 
previously shown to influence bone ultrasound measurements in this population (22, 32). 164 
Participants were excluded from analyses if they had missing values for any variables 165 
included in the multivariate model (n=1672, 41.8%). In a similar way, differences in calcaneal 166 
BUA across sex-specific groups of serum magnesium concentration were investigated using 167 
the same covariates, but excluding dietary factors in the adjusted model. Published guidance 168 
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suggests 0.7-1.0 mmol/L should be used as a normal reference range (33). Concentration 169 
groups were categorised as <0.7 mmol/L (group 1, deficient), 0.7-0.8 mmol/L (group 2), 0.8-170 
0.9 mmol/L (group 3), 0.9-1.0 mmol/L (group 4), and >1.0 mmol/L (group 5, excess). 171 
 172 
Prentice-weighted Cox regression was used to investigate associations between incidence of 173 
fractures and sex-specific quintiles of dietary magnesium, potassium, or Mg+K z-score intake. 174 
An unadjusted model without covariates was tested followed by a model adjusting for the 175 
aforementioned variables. The full case-cohort dataset described above, including the random 176 
subset and all fracture cases, was used for these analyses. Participants were excluded from 177 
analyses if they had missing values for any variables included in the adjusted model. For 178 
analysis of specific-site fracture risk (hip, spine, or wrist) other fracture data were excluded 179 
from the analysis unless contained in the subcohort, in order to retain a distinct control group. 180 
Total risk of hip spine or wrist fracture was calculated as the risk of an individual having one 181 
of these types of fracture. This total does not include multiple fractures and therefore the 182 
specific-site fracture incidences described may not sum to the total. The association between 183 
incidence of fractures and sex-specific groups of serum magnesium concentration was 184 
investigated, using the same covariates, but excluding dietary factors in the adjusted model. 185 
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RESULTS 186 
Descriptive statistics 187 
Selected characteristics are summarised in Table 1, for men and women, as mean values ± SD, 188 
or frequency and percentage for categorical variables. There were 968 men and 1360 women 189 
in the ultrasound cohort population with information for all selected variables; in the fracture 190 
case-cohort there were data for 1958 men and 2755 women. The mean age was 63.0 ± 9.3 for 191 
men and 61.7 ± 9.2 for women in the ultrasound cohort; in the fracture case-cohort mean age 192 
at baseline was 59.7 ± 9.6 for men and 59.8 ± 9.5 for women. Mean BMI was 26.9 ± 3.4 193 
kg/m2 for men and 26.5 ± 4.4 kg/m2 for women in the ultrasound cohort; in the fracture case-194 
cohort mean BMI at baseline was 26.5 ± 3.3 kg/m2 for men and 26.2 ± 4.3 kg/m2 for women. 195 
Mean total daily energy intake was 2263 ± 478 kcal for men and 1732 ± 374 kcal for women 196 
in the ultrasound cohort; in the fracture case-cohort mean intake at baseline was 2239 ± 514 197 
kcal for men and 1683 ± 385 kcal for women. Mean magnesium intake was 329 ± 92 mg/day 198 
for men and 277 ± 72 mg/day for women in the ultrasound cohort; in the fracture case-cohort 199 
mean intake at baseline was 321 ± 92 mg/day for men and 265 ± 73 mg/day for women; these 200 
values are slightly higher than the UK Reference Nutrient Intake (RNI) of 300 mg and 270 201 
mg (34), respectively. Mean calcium intake was 925 ± 282 mg/day for men and 782 ± 247 202 
mg/day for women in the ultrasound cohort; in the fracture case-cohort mean intake at 203 
baseline was 914 ± 296 mg/day for men and 762 ± 253 mg/day for women; these values are 204 
also higher than the UK RNI of 700 mg for all adults over 19 years old (34). Calcium 205 
supplements were used by 1.5% of men and 7.2% of women in the ultrasound cohort, and by 206 
1.3% of men and 5.6% of women in the fracture case-cohort. Mean potassium intake was 207 
3525 ± 803 mg/day for men and 3070 ± 662 mg/day for women in the ultrasound cohort; in 208 
the fracture case-cohort mean intake at baseline was 3445 ± 815 mg/day for men and 2969 ± 209 
690 mg/day for women. Potassium intake for women in this cohort is therefore lower than the 210 
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UK RNI of 3500 mg for all adults over 18 years old (34). Mean serum magnesium 211 
concentration was 0.81 ± 0.12 mmol/L for men (n=1006) and 0.79 ± 0.13 mmol/L for women 212 
(n=720). Vitamin D supplements were used by 23.6% of men and 34.6% of women in the 213 
ultrasound cohort, and by 22.0% of men and 31.8% of women in the fracture case-cohort. 214 
 215 
Current smokers represented 7.9% of men and 9.8% of women in the ultrasound cohort and 216 
the proportion of never smokers was higher for women than men (58.6% vs. 36.6%); in the 217 
fracture case-cohort current smokers and never smokers represented 12.2% and 32.6% of men, 218 
and 12.5% and 55.2% of women, respectively. There was a broad spread of physical activity 219 
levels across the four categories (inactive, moderately inactive, moderately active, or active) 220 
for both men and women, although there was a higher proportion of women classified as 221 
inactive or moderately inactive than men (59.1 vs. 52.8% ultrasound cohort; 64.8 vs. 55.5% 222 
fracture case-cohort). Family history of osteoporosis in the ultrasound cohort was 3.2% in 223 
men and 6.1% in women; in the fracture case-cohort it was 3.0% in men and 5.6% in women. 224 
The majority (72.1% ultrasound cohort; 64.1% fracture case-cohort) of women were post-225 
menopausal and 37.5% in ultrasound cohort and 28.9% in the fracture case-cohort were 226 
current or former users of hormone replacement therapy (HRT). Current or former users of 227 
corticosteroids for 3 months or more accounted for 4.4% of men and 5.2% of women in the 228 
ultrasound cohort; in the fracture case-cohort it was 2.6% of men and 3.5% of women. 229 
 230 
Associations between dietary magnesium and potassium intake and bone density 231 
Mean calcaneal BUA values stratified by quintiles of dietary magnesium, potassium, or 232 
Mg+K z-score intake, are shown in Figure 1 stratified by sex. Data are presented for the fully 233 
adjusted model. In men, no linear trends in fully adjusted BUA were apparent across quintiles 234 
of magnesium, potassium or Mg+K z-score intake. In women significant linear trends were 235 
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apparent across quintiles of potassium and Mg+K z-score intake, but not magnesium intake 236 
alone, for fully adjusted BUA (p=0.04, p=0.03 and p=0.15, respectively). Individual 237 
significant differences in fully adjusted BUA were also identified for women between quintile 238 
5 and quintile 1 for Mg+K z-score intake (74.6 ± 16.1 dB/MHz, n=272 vs. 70.8 ± 16.3 239 
dB/MHz, n=272; a 5.3% difference; p=0.02), but not potassium (74.0 ± 16.2 dB/MHz, n=272 240 
vs. 71.0 ± 16.3 dB/MHz, n=272; a 4.2% difference; p=0.05) or magnesium alone (73.9 ± 15.8 241 
dB/MHz, n=272 vs. 71.6 ± 16.2 dB/MHz, n=272; a 3.3% difference; p=0.11) (see Figure 1). 242 
No p values were below the Bonferroni-adjusted family-wise critical value (Supplementary 243 
Table 1). 244 
 245 
Associations between serum magnesium groups and bone density 246 
Analysis of bone density measures according to serum magnesium concentration groups, 247 
adjusting for all covariates previously described, with the exception of dietary factors, showed 248 
no significant differences in BUA in either men or women (see Figure 1 and Supplemental 249 
Table 1). Furthermore, no correlation was apparent between dietary magnesium intake and 250 
serum magnesium concentration for either men (r=0.01, p=0.87, n=717) or women (r=-0.04, 251 
p=0.25, n=1006). 252 
 253 
Associations between dietary magnesium and potassium intake and fracture risk 254 
Between baseline and follow-up, the percentage of men with one or more hip, spine, or wrist 255 
fractures was 23.4% lower in quintile 5 versus quintile 1 for magnesium intake quintiles, 256 
18.1% for potassium quintiles, and 10.2% for Mg+K z-score quintiles. In women these 257 
figures were 35.9%, 32.1% and 30.8%. Risk of hip fracture in men was significantly lower in 258 
Mg+K z-score quintiles 2 and 5 than quintile 1 in the fully adjusted model (p=0.03 and 259 
p=0.02) (Figure 2 and Supplemental Table 2). The lowest risk of hip fracture in men was 260 
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evident in Mg+K z-score quintile 5 (0.35 (95% CI: 0.14, 0.85)). In women, a significantly 261 
reduced risk of hip fracture was evident in Mg+K z-score quintile 4 versus quintile 1 in the 262 
fully adjusted model (0.59 (95% CI: 0.36, 0.97), p=0.04). A reduced risk of spinal fracture in 263 
women was evident for dietary magnesium quintile 3 versus quintile 1 (0.49 (95% CI: 0.25, 264 
0.97), p=0.04) (Figure 2 and Supplemental Table 3), but not Mg+K z-score or potassium 265 
quintiles (Figure 2, Supplementary Table 2 and Supplemental Table 4). No p values were 266 
below the Bonferroni-adjusted family-wise critical value (Supplementary Table 1). 267 
 268 
Analysis of risk of fracture according to concentration groups of serum magnesium showed a 269 
number of significant associations (Figure 2 and Supplemental Table 5). In men there were 270 
significant trends in fracture risk across serum concentration groups for spine fractures 271 
(p=0.02), and total hip, spine, and wrist fractures (p=0.02), but not for hip (p=0.06) or wrist 272 
fractures alone (p=0.38). Hip fracture risk was significantly lower in groups 2 (p=0.03) and 3 273 
(p<0.01) than group 1 in the fully adjusted model, with the lowest risk in group 3 (0.34 (95% 274 
CI: 0.17, 0.70)). Spinal fracture risk was significantly lower (0.20 (95% CI: 0.05, 0.75), 275 
p=0.02) in group 4 than group 1; total risk of hip, spine, and wrist fractures was significantly 276 
lower in groups 2 (p=0.03), 3 (p=0.03), and 4 (p<0.01) than group 1, with the lowest risk in 277 
group 4 (0.41 (95% CI: 0.22, 0.77)). In women there were no significant trends for fracture 278 
risk across groups of magnesium serum concentration, nor between specific groups compared 279 
to group 1. No p values were below the Bonferroni-adjusted family-wise critical value 280 
(Supplementary Table 1). 281 
282 
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DISCUSSION 282 
This study has shown significant associations between combined dietary magnesium and 283 
potassium intake and a quantitative measure of bone density, with significantly higher 284 
calcaneal BUA evident in women in the highest versus lowest Mg+K z-score intake quintiles 285 
of these micronutrients, after adjustment for important biological, lifestyle and other dietary 286 
covariates. Furthermore, risk of hip fracture in both women and men was significantly 287 
reduced in specific higher Mg+K intake quintiles compared to the lowest. We believe this 288 
study is also the first to show lower total risk of hip, spine, or wrist fracture for men with a 289 
clinically normal serum magnesium concentration compared to those classed as deficient. 290 
However, while each of the described associations was significant individually, no significant 291 
associations were evident after adjusting for multiple-testing. 292 
 293 
The mechanisms by which magnesium and potassium may influence bone metabolism are not 294 
fully understood, although a number of theories have been proposed. Insufficient magnesium 295 
results in an increased rate of hydroxyapatite formation, resulting in larger crystals and thus 296 
lower bone mass and brittle bones which may be unable to support normal loads. Magnesium 297 
also has an effect on osteoblast activity and osteoclast number through a nitric oxide 298 
dependent mechanism (10), and both magnesium and potassium affect bone metabolism 299 
through altered calcium homeostasis via influences on calcium transport and urinary retention 300 
(9, 10, 14). A number of other studies investigating associations between magnesium and 301 
potassium and bone health, either individually or in combination, have demonstrated some 302 
degree of improvement with higher intake (4-7, 13, 19, 20), and thus the results presented 303 
here largely corroborate these findings. However, a recent USA study (7) of post-menopausal 304 
women found no difference in relative risk of hip and total fractures across quintiles of 305 
magnesium intake.  Conversely, high magnesium intake (≥422.5 mg/day) was associated with 306 
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increased falls and wrist or lower-arm fractures (7). By contrast, our analyses show significant 307 
reduction in hip fracture risk with moderately high (206-442 mg/day; quintile 4) combined 308 
magnesium and potassium intakes, and no significant increases in risk of wrist fracture in 309 
either men or women in fully adjusted models, although it is acknowledged that the 95% 310 
confidence intervals for wrist fracture risk are wide. Differences between the population 311 
groups in the two studies with respect to genetics, demographic lifestyle, the range of 312 
magnesium intakes, and dietary analysis methods (Orchard et al (7) used FFQs) may explain 313 
the discrepancy (27, 35). Also the Orchard study (7) did not present their results adjusted for 314 
potassium and energy, although they stated that potassium did not modify the associations 315 
between magnesium and fracture risk. 316 
 317 
The magnitude of the differences seen here is similar to data published by other authors. For 318 
example, fully adjusted BUA was 5.3% greater (+3.8 dB/MHz) in Mg+K z-score quintile 5 319 
versus quintile 1 for women. This compares to 3.5% and 3.8% increases in lumbar spine 320 
BMD for premenopausal women quartile 4 versus quartile 1 of dietary magnesium and 321 
potassium intakes, respectively (8). Also similar are results from Ryder et al (19) and Orchard 322 
et al (7) showing whole body BMD was 4.0% greater and 3.0% greater, respectively, for 323 
women in magnesium quintile 5 versus quintile 1. Tucker et al (5) show larger differences in 324 
BMD across quartiles of combined magnesium and potassium: quartile 4 versus quartile 1 for 325 
women had 12.8% greater lumbar spine BMD, although the relatively old age and limited 326 
number in this group (562 women, 69-97 years old) could explain the greater differences seen. 327 
In terms of the implications of the magnitude of change seen in the current study, previous 328 
published data for this cohort showed a 5 dB/MHz greater BUA was associated with HRT use, 329 
and that a 20 dB/MHz decline in BUA approximately doubled fracture risk (36), thus 330 
demonstrating the relevance of our observations. 331 
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 332 
Our findings showed no correlation between dietary magnesium intake and serum magnesium 333 
concentration for either men or women. Although supplementation studies with magnesium 334 
have demonstrated that serum is a suitable biomarker for diet, other studies like ours found no 335 
relationship between dietary and serum magnesium; this is likely a reflection of the tight 336 
homeostatic control of this cation in the circulation (37-39). However, while serum 337 
magnesium concentration was not associated with calcaneal BUA, nor risk of hip, spine, or 338 
wrist fracture in women, a number of significant associations with fracture risk were evident 339 
in men, with those in the healthy normal clinical range, 0.7-1.0 mmol/L (33), showing 340 
significantly reduced risk compared to those with sub-optimal concentrations. 341 
 342 
Strengths and Limitations 343 
In the UK, dietary intake of magnesium is mainly provided by fruit and vegetables, cereals, 344 
and beverages; potassium is provided by dietary fruit and vegetables, meat, potato, and 345 
savoury snacks (40). Accurate estimation of dietary nutrient intake is critical to the findings of 346 
this type of study. The methodology used here of quantitative 7-day food diaries has been 347 
validated previously and is expected to have provided more precise dietary intake figures 348 
compared to FFQs or 24-hour recall methods (27). Indeed previous UK EPIC analyses have 349 
shown correlations between potassium intake estimated from food diary data and 24 hour 350 
potassium excretion were significantly greater than for FFQ or 24-hour recall (41). It is 351 
reasonable to assume that this validity would also translate to magnesium. The strong 352 
collinearity between dietary intake of magnesium and potassium, a likely consequence of 353 
magnesium rich food typically also being rich in potassium, makes it difficult to differentiate 354 
individual effects of these nutrients on bone density. Other studies have considered this to 355 
varying degrees, but an appropriate compromise is achieved by presenting data using 356 
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standardised magnesium and potassium intakes which have been combined and re-357 
standardised (5), thus the inclusion of this data analysis is a strength of this work. Previous 358 
use of this methodology was confined to analyses of BMD measures alone (5), making our 359 
additional longitudinal analysis of fracture risk valuable. Hospital admission data was used to 360 
determine fracture incidence and it is acknowledged this may underestimate incidence, 361 
particularly for spine fractures, and could differ between sexes. We used a subset of the EPIC-362 
Norfolk dietary data and, in order to reduce the potential for bias, included randomly selected 363 
participants from the cohort. Magnesium and potassium dietary data were derived from food 364 
intake only, and therefore may underestimate total nutrient intakes, although supplements 365 
consumed by this cohort provide a relatively small contribution to mineral intakes (42); we 366 
included calcium and vitamin D supplement use in our models nevertheless. We acknowledge 367 
that mineral contributions of drinking and bottled water may be imprecise due to varying 368 
concentrations not detailed sufficiently in food composition tables. Although this 369 
observational study cannot show causality in effects, this report is, to our knowledge, the first 370 
to provide analysis of bone quality and fracture risk by magnesium serum concentration 371 
groups in addition to dietary intake in a general population of both men and women. 372 
 373 
Conclusions 374 
This study has positively associated dietary magnesium and potassium intake with a 375 
quantitative ultrasound measure of bone density status and reduced fracture risk in a mixed 376 
UK population group of men and pre- and post-menopausal women. These results thus 377 
support policies to promote a good quality diet with sufficient magnesium and potassium 378 
intake. Clinically normal serum magnesium concentration, compared to suboptimal 379 
concentration, has also been shown to be associated with reduced risk of incident fracture in 380 
men. Further study will be required to determine how generalisable the results of these 381 
19 
analyses are, and to fully understand the relationship between intake of these micronutrients, 382 
bone health, and osteoporosis. 383 
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TABLES AND FIGURES 
Table 1 – Selected characteristics of the EPIC-Norfolk cohort population stratified by sex for the ultrasound cohort group (n=2328) and the fracture 
case-cohort group (n=4713). 
 
Selected Characteristics Ultrasound cohort1  Fracture case-cohort2  
 Men Women  Men Women  
 n=968 n=1360 P3 n=1958 n=2755 P 
Age (years) 63.0 ± 9.34 61.7 ± 9.2 <0.001 59.7 ± 9.6 59.8 ± 9.5 0.809 
BMI (kg/m2) 26.9 ± 3.4 26.5 ± 4.4 0.039 26.5 ± 3.3 26.2 ± 4.3 0.004 
Magnesium intake (mg/day) 329 ± 92 277 ± 72 <0.001 321 ± 92 265 ± 73 <0.001 
Potassium intake (mg/day) 3525 ± 803 3070 ± 662 <0.001 3445 ± 815 2969 ± 690 <0.001 
Calcium intake (mg/day) 925 ± 282 782 ± 247 <0.001 914 ± 296 762 ± 253 <0.001 
Calcium supplement use 14 (1.5) 98 (7.2) <0.001 25 (1.3) 155 (5.6) <0.001 
Vitamin D supplement use 228 (23.6) 471 (34.6) <0.001 430 (22.0) 875 (31.8) <0.001 
Total energy intake (kcal/day) 2263 ± 478 1732 ± 374 <0.001 2239 ± 514 1683 ± 385 <0.001 
Serum [Mg] (mmol/L) 0.81 ± 0.125 0.79 ± 0.136 0.003 0.81 ± 0.127 0.79 ± 0.138 0.001 
BUA (dB/MHz) 89.6 ± 17.4 72.1 ± 16.5 <0.001 -- --  
Smoking   <0.001   <0.001 
     Current 76 (7.9) 133 (9.8)  238 (12.2) 343 (12.5)  
     Former 538 (55.6) 430 (31.6)  1082 (55.3) 890 (32.3)  
     Never 354 (36.6) 797 (58.6)  638 (32.6) 1522 (55.2)  
Physical activity   <0.001   <0.001 
     Inactive 275 (28.4) 342 (25.1)  614 (31.4) 908 (33.0)  
     Moderately inactive 236 (24.4) 462 (34.0)  472 (24.1) 877 (31.8)  
     Moderately active 248 (25.6) 333 (24.5)  436 (22.3) 577 (20.9)  
     Active 209 (21.6) 223 (16.4)  436 (22.3) 393 (14.3)  
27 
Family history of osteoporosis   0.001   <0.001 
     No 937 (96.8) 1277 (93.9)  1900 (97.0) 2601 (94.4)  
     Yes 31 (3.2) 83 (6.1)  58 (3.0) 154 (5.6)  
Corticosteroid use   0.391   0.243 
     Current or former (>3 months) 43 (4.4) 71 (5.2)  50 (2.6) 97 (3.5)  
     Never (<3 months) 925 (95.6) 1289 (94.8)  1908 (97.5) 2658 (96.5)  
Menopausal status       
     Pre-menopausal -- 86 (6.3)  -- 414 (15.0)  
     Peri-menopausal (<1 y) -- 47 (3.5)  -- 127 (4.6)  
     Peri-menopausal (1-5 y) -- 246 (18.1)  -- 448 (16.3)  
     Post-menopausal -- 981 (72.1)  -- 1766 (64.1)  
HRT       
     Current -- 288 (21.2)  -- 472 (17.1)  
     Former -- 222 (16.3)  -- 324 (11.8)  
     Never -- 850 (62.5)  -- 1959 (71.1)  
1Ultrasound group characteristics at 2nd health-check (time of ultrasound). 
2Fracture group characteristics at 1st health-check or time of consent. 
3P values are for differences between men and women for each applicable variable, according to t-test for continuous or chi-square for categorical 
variables.  
4Values are mean ± SD or frequency (percentage). 
5n=720. 6n=1006. 7n=1460. 8n=2009 
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Figure 1 – Fully adjusted1 calcaneal Broadband Ultrasound Attenuation (BUA) of the EPIC-
Norfolk cohort population (968 men and 1360 women) stratified by sex and quintiles of 
Magnesium2 or Potassium3 dietary intake, z-score quintiles of dietary Magnesium+Potassium4 
intake, or serum Magnesium concentration groups5 (720 men and 1006 women).  
 
* p≤0.05 versus quintile 1, according to ANCOVA (not significant after multiple testing adjustment). 
1Adjusted for: age, BMI, smoking status, physical activity, family history of osteoporosis, 
menopausal and HRT status in women, corticosteroid use, calcium intake and supplement use 
(excluding serum Mg model), vitamin D supplement use (excluding serum Mg model), and total 
energy intake (excluding serum Mg model). Values are presented as mean ± SD. 
2Mg intake (mean ± SD; mg/day) by Mg quintiles (Q). Men: mean, 329 ± 32; Q1, 218 ± 31; Q2, 
277 ± 12; Q3, 319 ± 13; Q4, 366 ± 16; Q5, 466 ± 73. Women: mean, 277 ± 72; Q1, 189 ± 26; Q2, 
237 ± 10; Q3, 270 ± 10; Q4, 307 ± 12; Q5, 383 ± 58. 
3K intake (mean ± SD; mg/day) by K quintiles. Men: mean, 3525 ± 803; Q1, 2505 ± 344; Q2, 
3099 ± 125; Q3, 3478 ± 101; Q4, 3854 ± 122; Q5, 4697 ± 603. Women: mean, 3070 ± 662; Q1, 
2196 ± 287; Q2, 2721 ± 99; Q3, 3038 ± 90; Q4, 3367 ± 106; Q5, 4030 ± 429. 
4Mg intake (mean ± SD; mg/day) by Mg+K z-score quintiles. Men: mean 329 ± 92; Q1, 221 ± 35; 
Q2, 279 ± 22; Q3, 321 ± 29; Q4, 364 ± 29; Q5, 460 ± 78. Women: mean 277 ± 72; Q1, 192 ± 29; 
Q2, 238 ± 19; Q3, 271 ± 21; Q4, 306 ± 24; Q5, 378 ± 61. K intake (mean ± SD; mg/day) by 
Mg+K z-score quintiles. Men: mean 3525 ± 803; Q1, 2539 ± 375; Q2, 3117 ± 218; Q3, 3489 ± 
229; Q4, 3857 ± 270; Q5, 4630 ± 668. Women: mean 3070 ± 662; Q1, 2217 ± 309; Q2, 2753 ± 177; 
Q3, 3047 ± 205; Q4, 3351 ± 230; Q5, 3983 ± 479. 
5Serum Mg concentration groups: <0.7 mmol/L (group 1), 0.7-0.8 mmol/L (group 2), 0.8-0.9 
mmol/L (group 3), 0.9-1.0 mmol/L (group 4), and >1.0 mmol/L (group 5). 
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Figure 2 – Risk1 of hip, spine, and wrist fractures in the EPIC-Norfolk cohort population (1958 
men and 2755 women) at follow-up versus baseline stratified by sex and quintile of Magnesium2 or 
Potassium3 dietary intake, z-score quintiles of dietary Magnesium+Potassium4 intake, or serum 
Magnesium concentration groups5 (1460 men and 2009 women). (Prentice-weighted Cox 
proportional hazard ratio and 95% CI of quintiles or groups, quintile or group 1 as reference).  
 
 * p≤0.05 versus quintile 1, according to ANCOVA; ** p≤0.01 (not significant after multiple testing 
adjustment). Insufficient data was available in the highest serum Mg concentration group for some 
hazard ratio calculations. 
1Adjusted for: age, BMI, smoking status, physical activity, family history of osteoporosis, 
menopausal and HRT status in women, corticosteroid use, calcium intake and supplement use 
(excluding serum Mg model), vitamin D supplement use (excluding serum Mg model), and total 
energy intake (excluding serum Mg model). Values are presented as mean ± SD. 
2Mg intake (mean ± SD; mg/day) by Mg quintiles (Q). Men: mean, 321 ± 93; Q1, 209 ± 31; Q2, 
268 ± 12; Q3, 312 ± 13; Q4, 358 ± 15; Q5, 460 ± 75. Women: Mean, 265 ± 73; Q1, 175 ± 25; Q2, 
223 ± 10; Q3, 257 ± 9; Q4, 294 ± 13; Q5, 373 ± 59. 
3K intake (mean ± SD; mg/day) by K quintiles. Men: mean, 3449 ± 821; Q1, 2390 ± 356; Q2, 
3019 ± 119; Q3, 3405 ± 111; Q4, 3797 ± 126; Q5, 4635 ± 607. Women: mean, 2964 ± 689; Q1, 
2065 ± 285; Q2, 2595 ± 102; Q3, 2921 ± 92; Q4, 3268 ± 113; Q5, 3974 ± 448. 
4Mg intake (mean ± SD; mg/day) by Mg+K z-score quintiles. Men: mean 321 ± 93; Q1, 212 ± 35; 
Q2, 271 ± 23; Q3, 314 ± 28; Q4, 357 ± 28; Q5, 454 ± 80. Women: mean 265 ± 73; Q1, 178 ± 29; 
Q2, 225 ± 19; Q3, 257 ± 20; Q4, 294 ± 24; Q5, 368 ± 63. K intake (mean ± SD; mg/day) by 
Mg+K z-score quintiles. Men: mean 3449 ± 821; Q1, 2422 ± 386; Q2, 3040 ± 212; Q3, 3419 ± 
245; Q4, 3788 ± 263; Q5, 4577 ± 663. Women: mean 2964 ± 687; Q1, 2087 ± 307; Q2, 2618 ± 183; 
Q3, 2925 ± 189; Q4, 3257 ± 223; Q5, 3935 ± 490.  
5Serum Mg concentration groups: <0.7 mmol/L (group 1), 0.7-0.8 mmol/L (group 2), 0.8-0.9 
30 
mmol/L (group 3), 0.9-1.0 mmol/L (group 4), and >1.0 mmol/L (group 5). 
Men Women 
Mg 
K 
Mg+K 
* 
[Mg] 
P trend = 0.04 
P trend = 0.03 
Men Women 
Mg 
K 
Mg+K 
[Mg] 
* 
* * * 
* ** * * ** * 
P trend = 0.02 
P trend = 0.02 
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Supplemental Table 1 – Families of tests and their hypotheses included in this study of the EPIC-Norfolk cohort population. 
  Mg K Mg+K  
Experiment/family hypothesis  Trend Q2 
vs. 
Q1 
Q3 
vs. 
Q1 
Q4 
vs. 
Q1 
Q5 
vs. 
Q1 
Trend Q2 
vs. 
Q1 
Q3 
vs. 
Q1 
Q4 
vs. 
Q1 
Q5 
vs. 
Q1 
Trend Q2 
vs. 
Q1 
Q3 
vs. 
Q1 
Q4 
vs. 
Q1 
Q5 
vs. 
Q1 
Family-wise 
critical p 
Dietary intake of Mg and/or K has 
no association with BUA in men 
 0.44 0.19 0.07 0.43 0.21 0.31 0.87 0.72 0.21 0.55 0.70 0.69 0.76 0.57 0.72 P < 0.0033 
(0.05/15) 
Dietary intake of Mg and/or K has 
no association with BUA in women 
 0.15 0.95 0.77 0.98 0.11 0.04 0.81 0.63 0.24 0.05 0.03 0.36 0.97 0.29 0.02 P < 0.0033 
(0.05/15) 
Serum Mg concentration has no 
association with BUA in men 
 0.97 0.10 0.21 0.61 0.83 -- -- -- -- -- -- -- -- -- -- P < 0.01 
(0.05/5) 
Serum Mg concentration has no 
association with BUA in women 
 0.24 0.12 0.54 0.51 0.28 -- -- -- -- -- -- -- -- -- -- P < 0.01 
(0.05/5) 
Total 0.69 0.94 0.77 0.15 0.69 0.46 0.99 0.42 0.37 0.75 0.56 0.08 0.37 0.69 0.16 
Hip 0.73 0.71 0.91 0.55 0.34 0.16 0.32 0.56 0.23 0.14 0.25 0.03 0.29 0.73 0.02 
Spine 0.60 0.33 0.59 0.24 0.54 0.57 0.45 0.51 0.56 0.47 0.76 0.21 0.45 0.97 0.81 
Dietary intake of Mg and/or K has 
no association with risk of fracture 
in men 
Wrist 0.21 0.13 0.10 0.06 0.16 0.43 0.39 0.46 0.46 0.28 0.51 0.34 0.22 0.21 0.42 
P < 0.00083 
(0.05/60) 
Total 0.18 0.40 0.50 0.45 0.18 0.82 0.50 0.85 0.60 0.80 0.36 0.27 0.87 0.09 0.47 
Hip 0.37 0.51 0.65 0.14 0.57 0.84 0.39 0.76 0.98 0.56 0.42 0.35 0.81 0.04 0.75 
Spine 0.11 0.32 0.04 0.14 0.14 0.45 0.27 0.28 0.06 0.73 0.21 0.14 0.08 0.13 0.21 
Dietary intake of Mg and/or K has 
no association with risk of fracture 
in women 
Wrist 0.34 0.47 0.72 1.00 0.14 0.75 0.54 0.99 0.96 0.51 0.77 0.73 0.61 0.95 0.56 
P < 0.00083 
(0.05/60) 
Total 0.02 0.03 0.03 0.005 0.53 -- -- -- -- -- -- -- -- -- -- 
Hip 0.06 0.03 0.003 0.07 -- -- -- -- -- -- -- -- -- -- -- 
Spine 0.02 0.47 0.23 0.02 0.97 -- -- -- -- -- -- -- -- -- -- 
Serum Mg concentration has no 
association with risk of fracture in 
men 
Wrist 0.38 0.08 0.41 0.05 0.96 -- -- -- -- -- -- -- -- -- -- 
P < 0.0025 
(0.05/20) 
Total 0.78 0.46 0.44 0.87 0.60 -- -- -- -- -- -- -- -- -- -- 
Hip 0.76 0.79 0.79 0.70 0.96 -- -- -- -- -- -- -- -- -- -- 
Spine 0.22 0.80 0.21 0.80 -- -- -- -- -- -- -- -- -- -- -- 
Serum Mg concentration has no 
association with risk of fracture in 
women 
Wrist 0.18 0.72 0.75 0.17 0.44 -- -- -- -- -- -- -- -- -- -- 
P < 0.0025 
(0.05/20) 
ONLINE SUPPLEMENTAL MATERIAL 
 
P values are quoted to 3 decimal places when less than 0.01, otherwise 2 decimal places are used. 
Supplemental Table 2 – Risk of hip, spine, and wrist fractures in the EPIC-Norfolk cohort population (1958 men and 2755 women) at follow-up versus 
baseline, stratified by z score quintiles of dietary Magnesium+Potassium intake (Prentice-weighted Cox proportional hazard ratio and 95% CI). 
Men  Dietary Magnesium+Potassium Intake  
  Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 P for trend 
Total1 
 
248/1958 60/392 46/392 48/391 54/392 40/391  
 Full Model2 1.0 (ref) 0.66 (0.41-1.05) 0.80 (0.49-1.30) 0.91 (0.56-1.46) 0.66 (0.37-1.18) 0.56 
Hip 112/1843 37/369 21/369 21/368 24/369 9/368  
 Full Model 1.0 (ref) 0.49 (0.25-0.93)* 0.69 (0.34-1.37) 0.88 (0.44-1.77) 0.35 (0.14-0.85)* 0.25 
Spine 78/1809 19/362 13/362 13/362 18/362 15/361  
 Full Model 1.0 (ref) 0.59 (0.26-1.35) 0.72 (0.31-1.69) 0.98 (0.43-2.25) 0.88 (0.31-2.51) 0.76 
Wrist 70/1807 7/362 13/361 16/362 17/361 17/361  
 Full Model 1.0 (ref) 1.60 (0.61-4.16) 1.79 (0.71-4.50) 1.76 (0.72-4.28) 1.49 (0.57-3.91) 0.51 
Women   P for trend 
Total 
 
616/2755 156/551 127/551 126/551 99/551 108/551  
 Full Model 1.0 (ref) 0.84 (0.62-1.14) 0.97 (0.70-1.35) 0.74 (0.51-1.05) 0.87 (0.58-1.28) 0.36 
Hip 339/2526 92/506 73/505 70/505 44/505 60/505  
 Full Model 1.0 (ref) 0.83 (0.56-1.23) 0.95 (0.63-1.44) 0.59 (0.36-0.97)* 0.92 (0.54-1.55) 0.42 
Spine 124/2335 38/467 26/467 19/467 19/467 22/467  
 Full Model 1.0 (ref) 0.66 (0.38-1.15) 0.56 (0.29-1.08) 0.58 (0.29-1.17) 0.62 (0.30-1.30) 0.21 
Wrist 218/2410 49/482 43/482 49/482 42/482 35/482  
 Full Model 1.0 (ref) 0.92 (0.58-1.46) 1.13 (0.71-1.81) 1.02 (0.61-1.70) 0.85 (0.48-1.48) 0.77 
1 Total risk is for an individual having a hip, spine, or wrist fracture, thus specific fracture incidences may not sum to total. 
ONLINE SUPPLEMENTAL MATERIAL 
 
2 Full model: age, BMI, smoking status, physical activity, family history of osteoporosis, menopausal and HRT status in women, corticosteroid use, calcium 
intake and supplement use, vitamin D supplement use, and total energy intake. * p≤0.05 versus quintile 1 (not significant after multiple testing adjustment).
ONLINE SUPPLEMENTAL MATERIAL 
 
Supplemental Table 3 – Risk of hip, spine, and wrist fractures in the EPIC-Norfolk cohort population (1958 men and 2755 women) at follow-up versus 
baseline, stratified by quintiles of dietary Magnesium intake (Prentice-weighted Cox proportional hazard ratio and 95% CI). 
Men  Dietary Magnesium Intake  
  Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 P for trend 
Total1 
 
248/1958 51/392 49/392 51/391 58/392 39/391  
 Full Model2 1.0 (ref) 0.98 (0.62-1.56) 1.07 (0.67-1.74) 1.46 (0.88-2.41) 0.89 (0.52-1.55) 0.69 
Hip 112/1843 31/369 24/369 24/368 21/369 12/368  
 Full Model 1.0 (ref) 0.89 (0.47-1.67) 1.04 (0.54-2.01) 1.24 (0.61-2.50) 0.67 (0.30-1.51) 0.73 
Spine 78/1809 17/362 12/362 14/362 24/362 11/361  
 Full Model 1.0 (ref) 0.66 (0.28-1.53) 0.80 (0.35-1.82) 1.68 (0.71-4.00) 0.72 (0.25-2.06) 0.60 
Wrist 70/1807 5/362 14/361 16/362 18/361 17/361  
 Full Model 1.0 (ref) 2.34 (0.78-7.06) 2.51 (0.85-7.43) 2.79 (0.94-8.26) 2.26 (0.72-7.03) 0.21 
Women   P for trend 
Total 
 
616/2755 159/551 124/551 120/551 111/551 102/551  
 Full Model 1.0 (ref) 0.88 (0.64-1.19) 0.89 (0.64-1.24) 0.81 (0.57-1.16) 0.77 (0.52-1.13) 0.18 
Hip 339/2526 93/506 70/505 66/505 52/505 58/505  
 Full Model 1.0 (ref) 0.87 (0.58-1.31) 0.91 (0.60-1.38) 0.70 (0.44-1.12) 0.87 (0.53-1.43) 0.37 
Spine 124/2335 39/467 27/467 16/467 21/467 21/467  
 Full Model 1.0 (ref) 0.76 (0.44-1.31) 0.49 (0.25-0.97)* 0.61 (0.31-1.18) 0.59 (0.29-1.18) 0.11 
Wrist 218/2410 53/482 42/482 43/482 48/482 32/482  
 Full Model 1.0 (ref) 0.84 (0.53-1.33) 0.91 (0.56-1.49) 1.00 (0.61-1.64) 0.64 (0.35-1.16) 0.34 
1 Total risk is for an individual having a hip, spine, or wrist fracture, thus specific fracture incidences may not sum to total. 
ONLINE SUPPLEMENTAL MATERIAL 
 
2 Full model: age, BMI, smoking status, physical activity, family history of osteoporosis, menopausal and HRT status in women, corticosteroid use, calcium 
intake and supplement use, vitamin D supplement use, and total energy intake. * p≤0.05 versus quintile 1 (not significant after multiple testing adjustment).
ONLINE SUPPLEMENTAL MATERIAL 
 
Supplemental Table 4 – Risk of hip, spine, and wrist fractures in the EPIC-Norfolk cohort population (1958 men and 2755 women) at follow-up versus 
baseline, stratified by quintiles of dietary Potassium intake (Prentice-weighted Cox proportional hazard ratio and 95% CI). 
Men  Dietary Potassium Intake  
  Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 P for trend 
Total1 
 
248/1958 55/392 56/392 48/391 44/392 45/391  
 Full Model2 1.0 (ref) 1.00 (0.65-1.54) 0.83 (0.53-1.31) 0.80 (0.50-1.29) 0.91 (0.52-1.59) 0.46 
Hip 112/1843 34/369 24/369 26/368 18/369 10/368  
 Full Model 1.0 (ref) 0.72 (0.38-1.37) 0.83 (0.45-1.54) 0.65 (0.33-1.31) 0.50 (0.20-1.27) 0.16 
Spine 78/1809 15/362 19/362 11/362 17/362 16/361  
 Full Model 1.0 (ref) 1.34 (0.63-2.82) 0.74 (0.31-1.79) 1.28 (0.56-2.89) 1.47 (0.52-4.15) 0.57 
Wrist 70/1807 8/362 13/361 14/362 15/361 20/361  
 Full Model 1.0 (ref) 1.49 (0.60-3.67) 1.39 (0.58-3.35) 1.40 (0.57-3.45) 1.66 (0.66-4.20) 0.43 
Women   P for trend 
Total 
 
616/2755 156/551 125/551 120/551 109/551 106/551  
 Full Model 1.0 (ref) 0.90 (0.67-1.22) 0.97 (0.70-1.34) 0.91 (0.65-1.28) 0.95 (0.65-1.40) 0.82 
Hip 339/2526 93/506 68/505 64/505 62/505 52/505  
 Full Model 1.0 (ref) 0.84 (0.57-1.24) 0.94 (0.61-1.44) 0.99 (0.64-1.54) 0.86 (0.51-1.43) 0.84 
Spine 124/2335 38/467 25/467 21/467 14/467 26/467  
 Full Model 1.0 (ref) 0.73 (0.42-1.28) 0.71 (0.39-1.31) 0.49 (0.23-1.04) 0.88 (0.42-1.85) 0.45 
Wrist 218/2410 53/482 41/482 45/482 43/482 36/482  
 Full Model 1.0 (ref) 0.87 (0.56-1.36) 1.00 (0.63-1.59) 0.99 (0.61-1.61) 0.84 (0.49-1.42) 0.75 
1 Total risk is for an individual having a hip, spine, or wrist fracture, thus specific fracture incidences may not sum to total. 
ONLINE SUPPLEMENTAL MATERIAL 
 
2 Full model: age, BMI, smoking status, physical activity, family history of osteoporosis, menopausal and HRT status in women, corticosteroid use, calcium 
intake and supplement use, vitamin D supplement use, and total energy intake.
ONLINE SUPPLEMENTAL MATERIAL 
 
Supplemental Table 5 – Risk of hip, spine, and wrist fractures in the EPIC-Norfolk cohort population (1460 men and 2009 women) at follow-up versus 
baseline, stratified by groups defined by serum Magnesium concentration (Prentice-weighted Cox proportional hazard ratio and 95% CI). 
Men  Serum Magnesium Concentration  
  Group 1 Group 2 Group 3 Group 4 Group 5 P for trend 
Total1 
 
183/1460 30/183 45/365 86/689 20/206 2/17  
 Full Model2 1.0 (ref) 0.56 (0.33-0.95)* 0.59 (0.36-0.95)* 0.41 (0.22-0.77)** 0.60 (0.12-2.93) 0.02 
Hip 82/1374 16/171 21/346 31/641 14/201 0/15  
 Full Model 1.0 (ref) 0.44 (0.20-0.93)* 0.34 (0.17-0.70)** 0.47 (0.21-1.07) -- 0.06 
Spine 56/1348 8/164 17/340 27/635 3/193 1/16  
 Full Model 1.0 (ref) 0.72 (0.30-1.74) 0.60 (0.26-1.38) 0.20 (0.05-0.75)* 0.96 (0.13-7.30) 0.02 
Wrist 52/1352 9/165 9/335 29/642 4/194 1/16  
 Full Model 1.0 (ref) 0.42 (0.16-1.11) 0.71 (0.32-1.60) 0.30 (0.09-1.01) 1.06 (0.12-9.21) 0.38 
Women   P for trend 
Total 
 
445/2009 53/285 131/603 209/881 47/215 5/25  
 Full Model 1.0 (ref) 1.16 (0.78-1.70) 1.16 (0.80-1.67) 0.96 (0.60-1.55) 0.74 (0.24-2.27) 0.78 
Hip 249/1848 27/265 69/553 121/808 28/198 4/24  
 Full Model 1.0 (ref) 1.07 (0.64-1.80) 1.07 (0.66-1.75) 0.88 (0.47-1.67) 1.03 (0.30-3.58) 0.76 
Spine 90/1704 14/251 29/513 34/733 13/187 0/20  
 Full Model 1.0 (ref) 0.91 (0.46-1.81) 0.65 (0.33-1.28) 0.90 (0.39-2.08) -- 0.22 
Wrist 218/1757 19/254 48/528 78/767 11/187 1/21  
 Full Model 1.0 (ref) 1.11 (0.63-1.94) 1.09 (0.64-1.85) 0.58 (0.27-1.26) 0.44 (0.05-3.53) 0.18 
1 Total risk is for an individual having a hip, spine, or wrist fracture, thus specific fracture incidences may not sum to total. 
ONLINE SUPPLEMENTAL MATERIAL 
 
2 Full model: age, BMI, smoking status, physical activity, family history of osteoporosis, menopausal and HRT status in women, and corticosteroid use. * 
p≤0.05 versus quintile 1; ** p≤0.01 (not significant after multiple testing adjustment). 
